Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q2 2016 · 10-Q
Revenue$236.06K$236.06K+24.8% vs Q2 2015 Net Income-$11.85K-$11.85KN/M vs Q2 2015 EPS Diluted$0.00$0.00— vs Q2 2015 Gross Profit$122,487+42.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flowderived-$38,049N/M Free Cash Flowderived-$45,819N/M Margins · derivedGross margin51.9%+6.4 pt vs Q2 2015
Operating margin-5.2%+3.2 pt vs Q2 2015
Net margin-5.0%+3.2 pt vs Q2 2015
ended Jun 30, 2016 · filed Nov 15, 2016 · 138 d after period end